Rxo, Inc. · NYSE:RXO
Finepoint Capital LP reported a 5.70% stake in Rxo, Inc. (Schedule 13G)
Event Dec 31, 2025 · Filed Feb 13, 2026
Finepoint Capital LP reported a 5.70% stake in Rxo, Inc., 9,388,789 shares, as a passive investor on Dec 31, 2025. Filed Feb 13, 2026 (Schedule 13G).
- Stake
- 5.70%
- Shares
- 9,388,789
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Finepoint Capital LP | 5.70% | 9,388,789 |
| Herbert Wagner | 5.70% | 9,388,789 |
Source
Related
- Rxo, Inc.
- Finepoint Capital LP
- Rxo, Inc. shareholders
- Schedule 13G/A · Finepoint Capital LP · Aug 13, 2026
- Schedule 13D · MFN Partners, LP · Oct 5, 2026
- Form 4 · Harris James E · Sep 29, 2026
- Form 4 · Firestone Jeffrey D. · Aug 25, 2026
- Form 4 · Wilkerson Andrew M. · May 19, 2026
- Schedule 13G/A · Orbis Investment Management LTD · May 15, 2026